GENEXI
| GENEXI | |
|---|---|
 GENEXI ICO Review | |
| GENEXI ICO | |
| Ticker: | GEN |
| ICO start: | 2018-06-01 00:00:00 |
| ICO end: | 2018-08-31 00:00:00 |
| Price: | 1 GEN = 0.01 USD |
| Bonus: | 1 |
| Tokens: | 8400000000 |
| Tokentype: | ERC20 |
| Hardcap: | 70,000,000 USD |
| Softcap: | 20,000,000 USD |
| Raised: | 0 |
| Platform: | Ethereum |
| Distributed: | 70% |
| Accepting: | BTC, ETH, BCH, XMR, DSH, LTC, B2B, USDT |
There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market. Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.
Contents
Description
GENEXI combines the expertise of renowned specialists in the biotech industry to create a thriving ecosystem for biotech strartups and established pharmaceutical companies of different sizes and levels of operation.
GENEXFoundation is an organisation employing a wide range of high-profile biotech professionals to provide manual heuristic analysis for the most detailed venture assessment and evaluation.
GENEXFoundation will use its expertise and funds to select the most promising biotech startups for grant awarding.
GENEXPlatform is an innovative solution provided by the GENEXDev Team for the e-commerce market in order to support GENEXEcosystem development. The Platform will unite biotech producers, distributors, retailers and end-consumers in one blockchain-based solution operating as a global ecosystem.
Review
| “ | 2014 : Primary Scientific and Medical Research. Q1 2017: GENEXI Establishment. Q3 2017: Ecosystem and Platform Development. Q1 2018: Low Level Design Launch. Q3 2018: Ecosystem Alpha Version Testing. Q4 2018: Smart-Contract Development and Testing. Grant Application Program Launch. H1 2019: Ecosystem Complete Version Launch. H2 2019: Official Public GENEXI Accelerator Report. 2020: Further Ecosystem Development and Scaling.[1] | ” |
Team
| name: | title: | links: | group: | photo: | iss: |
|---|---|---|---|---|---|
| Katrina Arden | Escrow | https://www.linkedin.com/in/katrina-arden-70260426/ |  | 10.4 | |
| Alexey Zhelyaskov | Founder, CEO | https://www.linkedin.com/in/alexey-zhelyaskov-2a46aa15b/ |  | 4.4 | |
| Alexey Kirillov | Co-Founder, COO |  | 4.4 | ||
| Roman Gilvanov | Managing Director | https://www.linkedin.com/in/roman-gilvanov-29274073/ |  | 4.4 | |
| Sergey Tiurin | Head of Medical Research |  | 4.4 | ||
| Andrew Zharkov | Head of Finance |  | 4.4 | ||
| Alexey Nosikov | Head of Operations | https://www.linkedin.com/in/aleksey-nosikov/ |  | 4.4 | |
| Andrew Marcus | Head of Strategy | http://www.linkedin.com/in/andrew-chuyko-ab69854 |  | 4.4 | |
| Bogdan Stepanov | Head of Business Development | http://linkedin.com/in/bogdan-stepanov-963644a5 |  | 4.4 | |
| Anton Sklovets | Head of Research |  | 4.4 | ||
| Daria Goriychuk | Head of HR | https://www.linkedin.com/in/daria-goriychuk-09ba92162/ |  | 4.4 | |
| Alexander Novoselov | Biotech Analyst |  | 4.4 | ||
| Anton Nizhenkov | Investment Analyst | https://www.linkedin.com/in/anton-nizhenkov-701674147/ |  | 4.4 | |
| Dennis Sarkar | Ecosystem Developer | https://www.linkedin.com/in/dennis-sarkar-318267150/ |  | 4.4 | |
| Jacques Miabouna | Strategy Consultant |  | 4.4 | ||
| Vladimir Stark | Head of Marketing | https://www.linkedin.com/in/vandr/ |  | 5.4 | |
| Anastasia Verbitskaya | SMM | https://www.linkedin.com/in/anastasia-verbitskaya-a4b300119/ |  | 4.4 | |
| Denis Baldakov | Community Manager | https://www.linkedin.com/in/denis-baldakov |  | 4.4 | |
| Artem Targosh | Community manager | https://www.linkedin.com/in/artem-targosh-a475a8160/ |  | 4.4 | |
| Stepan Razenkov | Business Analyst |  | 4.4 | ||
| Anna Rafaelli | Chief Editor | https://www.facebook.com/annarafaelly |  | 4.4 | |
| Inna Leonova | Graphic Designer | https://www.linkedin.com/in/inna-leonova-38b969125/ |  | 4.4 | |
| Anna Fursova | PR Manager | https://www.facebook.com/Fursyy |  | 4.4 | |
| Margarita Ilina | PR Manager |  | 4.4 | ||
| Egor Stepanov | Head of IT | https://www.linkedin.com/in/egor-stepanov-852676163/ |  | 4.4 | |
| Alexander Abarevich | Technical Support Lead | https://www.linkedin.com/in/aleksandr-abarevich-57591494/ |  | 4.4 | |
| Anti Danilevski | ICO advisor | https://ru.linkedin.com/in/danilevski | Advisors |  | 4.4 |
| Malcolm Tan | Advisor | https://sg.linkedin.com/in/malcolmtan | Advisors |  | 15 |
| Roel Wolfert | Advisor | https://nl.linkedin.com/in/roelwolfert | Advisors |  | 7.4 |
| Philip McMaster | Advisor | https://cn.linkedin.com/in/philipmcmaster | Advisors |  | 4.4 |
| Richard O’Rourke | Advisor | https://www.linkedin.com/in/rsorourke/ | Advisors |  | 4.4 |
| Manuel Rimarachin | Advisor | https://www.linkedin.com/in/manuel-rimarachin-2137672a/ | Advisors |  | 4.4 |
External links
GENEXI on twitter
GENEXI on telegram
GENEXI on facebook
GENEXI on medium
GENEXI on bitcointalk
GENEXI on reddit
GENEXI on youtube
GENEXI official website
GENEXI whitepaper